FLNA
Filana Therapeutics, Inc.Company with tickers: FLNA
CIK
1069530
CUSIP
14817C107
Shares Outstanding
48,307,896
13F Activity (30d)
7 filings
6 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K | 2020-03-26 | 2019-12-31 | |
| 8-K | 2020-03-26 | — | |
| DEF 14A | 2020-03-26 | — | |
| 10-Q | 2020-05-06 | 2020-03-31 | |
| 8-K | 2020-05-06 | — | |
| 8-K | 2020-05-11 | — | |
| 8-K | 2020-05-15 | — | |
| 8-K | 2020-06-03 | — | |
| 8-K | 2020-06-19 | — | |
| 8-K | 2020-07-15 | — | |
| 10-Q | 2020-08-12 | 2020-06-30 | |
| 8-K | 2020-08-12 | — | |
| 8-K | 2020-09-01 | — | |
| 8-K | 2020-09-10 | — | |
| 8-K | 2020-09-14 | — | |
| 8-K | 2020-11-04 | — | |
| 8-K | 2020-11-09 | — | |
| 10-Q | 2020-11-09 | 2020-09-30 | |
| 8-K | 2020-11-13 | — | |
| 8-K | 2020-12-11 | — | |
| 8-K | 2021-01-06 | — | |
| 8-K | 2021-02-08 | — | |
| 8-K | 2021-02-12 | — | |
| 8-K | 2021-03-11 | — | |
| 10-K | 2021-03-23 | 2020-12-31 | |
| 8-K | 2021-03-23 | — | |
| DEF 14A | 2021-03-31 | 2020-12-31 | |
| 8-K | 2021-04-21 | — | |
| 10-Q | 2021-04-29 | 2021-03-31 | |
| 8-K | 2021-05-06 | — | |
| 8-K | 2021-06-14 | — | |
| 8-K | 2021-06-21 | — | |
| 8-K | 2021-08-03 | 2021-07-29 | |
| 8-K | 2021-08-03 | — | |
| 10-Q | 2021-08-04 | 2021-06-30 | |
| 8-K | 2021-11-10 | — | |
| 10-Q | 2021-11-15 | 2021-09-30 | |
| 8-K | 2022-01-06 | 2022-01-05 | |
| 8-K | 2022-02-28 | — | |
| 10-K | 2022-03-01 | 2021-12-31 | |
| DEF 14A | 2022-03-24 | 2021-12-31 | |
| 8-K | 2022-04-26 | — | |
| 10-Q | 2022-05-05 | 2022-03-31 | |
| 8-K | 2022-05-05 | — | |
| 8-K | 2022-05-09 | 2022-05-05 | |
| 8-K | 2022-08-03 | — | |
| 10-Q | 2022-08-04 | 2022-06-30 | |
| 8-K | 2022-09-23 | 2022-09-22 | |
| 8-K | 2022-10-27 | 2022-10-13 | |
| 8-K | 2022-11-03 | — |
Showing 1–50 of 133 filings